We are live on ! Find out more
CS

Credit Suisse Portfolio holdings

AUM $104B
1-Year Est. Return 34.76%
This Fund
S&P 500
This Quarter Est. Return
+6.17%
1 Year Est. Return
+34.76%
3 Year Est. Return
+49.35%
5 Year Est. Return
+181.01%
10 Year Est. Return
+395.52%
AUM
$112B
AUM Growth
+$9.72B
Cap. Flow
+$4.75B
Cap. Flow %
4.26%
Top 10 Hldgs %
20.07%
Holding
4,187
New
244
Increased
1,335
Reduced
1,929
Closed
426

Sector Composition

Rank Sector Weight
1 Technology 11.35%
2 Healthcare 10.59%
3 Financials 10.23%
4 Industrials 7.49%
5 Consumer Discretionary 6.82%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
RVNC
3251
DELISTED
Revance Therapeutics, Inc.
RVNC
$431K ﹤0.01%
17,318
-7,491
-30% -$204K
FLXN
3252
DELISTED
Flexion Therapeutics, Inc.
FLXN
$431K ﹤0.01%
23,054
-8,457
-27% -$194K
RTEC
3253
DELISTED
Rudolph Technologies Inc
RTEC
$431K ﹤0.01%
17,639
-10,955
-38% -$302K
FSCT
3254
DELISTED
ForeScout Technologies, Inc. Common Stock
FSCT
$430K ﹤0.01%
11,407
-1,908
-14% -$69.2K
WTTR icon
3255
Select Water Solutions
WTTR
$2.3B
$429K ﹤0.01%
36,210
-3,973
-10% -$54.6K
XENT
3256
DELISTED
Intersect ENT, Inc
XENT
$429K ﹤0.01%
14,938
-19,567
-57% -$588K
WLH
3257
DELISTED
WILLIAM LYON HOMES
WLH
$428K ﹤0.01%
26,901
-7,176
-21% -$149K
CNA icon
3258
CNA Financial
CNA
$14.2B
$426K ﹤0.01%
9,335
+566
+6% +$26.2K
SRLN icon
3259
State Street Blackstone Senior Loan ETF
SRLN
$5.3B
$426K ﹤0.01%
+8,999
New +$424K
CTRL
3260
DELISTED
Control4 Corporation
CTRL
$424K ﹤0.01%
12,337
-6,767
-35% -$209K
FFG
3261
DELISTED
FBL Financial Group
FFG
$423K ﹤0.01%
5,633
-3,225
-36% -$262K
LIT icon
3262
Global X Lithium & Battery Tech ETF
LIT
$1.51B
$422K ﹤0.01%
12,817
-97,202
-88% -$3.14M
MLAB icon
3263
Mesa Laboratories
MLAB
$564M
$419K ﹤0.01%
2,256
-931
-29% -$187K
BAC.WS.A
3264
CALL
DELISTED
Bank Of America Corporation Ws A
BAC.WS.A
$419K ﹤0.01%
23,550
LFCR icon
3265
Lifecore Biomedical
LFCR
$166M
$418K ﹤0.01%
29,021
-7,693
-21% -$106K
AKCA
3266
DELISTED
Akcea Therapeutics Inc
AKCA
$415K ﹤0.01%
11,841
-2,382
-17% -$72.1K
CMO
3267
DELISTED
Capstead Mortgage Corp.
CMO
$413K ﹤0.01%
52,109
-27,637
-35% -$233K
ABEO icon
3268
Abeona Therapeutics
ABEO
$366M
$412K ﹤0.01%
1,288
-157
-11% -$55.7K
UFI icon
3269
UNIFI
UFI
$119M
$410K ﹤0.01%
14,497
-1,743
-11% -$54.5K
FATE icon
3270
Fate Therapeutics
FATE
$286M
$407K ﹤0.01%
24,978
-8,218
-25% -$97.2K
LSAK icon
3271
Lesaka Technologies
LSAK
$396M
$406K ﹤0.01%
50,767
-2,492
-5% -$20.9K
TFIN icon
3272
Triumph Financial Inc
TFIN
$1.81B
$406K ﹤0.01%
10,636
+1,476
+16% +$61.3K
SNDA icon
3273
Sonida Senior Living
SNDA
$1.91B
$403K ﹤0.01%
2,850
-553
-16% -$75K
CDR
3274
DELISTED
Cedar Realty Trust, Inc
CDR
$402K ﹤0.01%
13,073
-4,210
-24% -$129K
FISI icon
3275
Financial Institutions
FISI
$816M
$400K ﹤0.01%
12,729
-4,188
-25% -$135K

Similar funds

Credit Suisse's Q3 2018 Portfolio in Review

As of Q3 2018, Credit Suisse held 4,187 positions worth $112B, up 9.5% from $102B the previous quarter. Its ten largest holdings account for 20% of the portfolio.

Credit Suisse deployed $4.75B of net new capital in Q3 2018, opening 244 new positions and adding to 1,335 existing holdings. Its largest new stake was Invesco Zacks Mid-Cap ETF: 1,600,000 shares worth $109M.

By sector, the portfolio is most concentrated in Technology at 11% of assets, up from 11% a quarter earlier, followed by Healthcare and Financials.

On the sell side, the largest reduction was UnitedHealth, an estimated $281M trimmed.

  • Credit Suisse's largest Q3 2018 buy was Invesco Zacks Mid-Cap ETF: 1,600,000 shares worth $109M.
  • Credit Suisse added most to State Street SPDR S&P 500 ETF Trust in Q3 2018, an estimated $1.14B increase.
  • Credit Suisse's biggest Q3 2018 reduction was UnitedHealth, cutting an estimated $281M.
  • Credit Suisse fully exited KraneShares CSI China Internet ETF in Q3 2018, selling an estimated $137M.
  • Credit Suisse's ten largest holdings make up 20% of its $112B portfolio in Q3 2018.
  • Credit Suisse opened 244 new positions and closed 426 in Q3 2018.
  • Credit Suisse's portfolio value rose 9.5% quarter-over-quarter to $112B.

Based on Credit Suisse's 13F filing for Q3 2018, filed 13 Nov 2018.